Related Experiment Video
Updated: Sep 17, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Characteristics and Outcomes of Fast Progressors Receiving Endovascular Treatment for Acute Large Vessel Occlusion: A
Mingming Zha1, Shuaiyu Chen2, Jinhua Wang1
1Department of Neurology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Insights
Fast progressors in acute large vessel occlusion strokes show higher severity, worse collaterals, and cardioembolic causes. These patients face worse outcomes after endovascular treatment (EVT), highlighting the need to consider infarction growth rate (IGR) in stroke management.
Area of Science:
- Neurology
- Interventional Neuroradiology
- Stroke Medicine
Background:
- Acute large vessel occlusion (LVO) stroke patients are categorized by infarction growth rate (IGR) into fast and slow progressors before endovascular treatment (EVT).
- Characteristics of fast progressors and the adverse effects of rapid infarction growth remain incompletely understood.
Purpose of the Study:
- To comprehensively review and characterize fast progressors in acute LVO stroke.
- To investigate the clinical outcomes associated with rapid infarction growth rate before EVT.
Main Methods:
- Systematic literature search of studies comparing fast and slow progressors before EVT, published up to March 24, 2025.
- Meta-analysis of baseline characteristics and clinical outcomes from 8 pooled studies involving 2,718 patients.
- Calculation of weighted odds ratios (OR) and mean differences (MD) with confidence intervals (CIs).
Main Results:
- Fast progressors exhibited higher NIH Stroke Scale scores, increased rates of intravenous thrombolysis, more internal carotid artery occlusions, and poorer collateral status.
- Cardioembolism was a prevalent etiology in fast progressors.
- Fast IGR was linked to lower successful reperfusion rates, reduced good functional outcomes (mRS 0-2), and higher rates of symptomatic intracranial hemorrhage and 90-day mRS scores.
Conclusions:
- Key features of fast progressors include stroke severity, proximal occlusion, poor collaterals, and cardioembolic etiology.
- Fast progressors face significantly increased risks of adverse outcomes following EVT.
- Incorporating IGR assessment into clinical practice and research is crucial for optimizing stroke management.
Introduction:
Acute large vessel occlusion patients can be categorized into fast and slow progressors based on infarction growth rate (IGR) before endovascular treatment (EVT). However, the characteristics of fast progressors remain uncertain, and a comprehensive review investigating the adverse effects of fast IGR is needed.
Methods:
A systematic search of studies published before March 24, 2025, was conducted using PubMed, Web of Science, Embase, and Cochrane Library following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Studies comparing fast and slow progressors before EVT were screened. Baseline characteristics and clinical outcomes were collected. Meta-analysis was performed to pool the results. Weighted odds ratio (OR), mean difference (MD), and confidence intervals (CIs) were calculated. This study was registered on the International Prospective Register of Systematic Reviews platform (CRD420251016945).
Results:
A total of 8 studies involving 2,718 patients were pooled. Age and gender were similar between fast and slow progressors. Fast progressors had significantly higher baseline National Institute of Health Stroke Scale scores (MD, 2.7; 95% CI, 2.0-3.4; I2 = 0), higher intravenous thrombolysis rates (OR, 1.41; 95% CI, 1.07-1.86; I2 = 62%), larger proportions of internal carotid artery occlusion (OR, 1.74; 95% CI, 1.39-2.19; I2 = 0), and lower percentages of good collateral status (OR, 0.33; 95% CI, 0.22-0.50; I2 = 53%). Cardioembolism etiology was also prevalent in fast progressors (OR, 1.42; 95% CI, 1.10-1.83; I2 = 0). Regarding outcomes, fast IGR was associated with significantly lower rates of successful reperfusion (OR, 0.70; 95% CI, 0.57-0.86; I2 = 0) and a modified Rankin Scale (mRS) score 0-2 at 90-day (OR, 0.34; 95% CI, 0.28-0.42; I2 = 0). Meanwhile, the proportions of symptomatic intracranial hemorrhage (OR, 3.54; 95% CI, 1.78-7.01; I2 = 33%) and 90-day mRS scores (MD, 0.94; 95% CI, 0.61-1.26; I2 = 51%) were higher in fast progressors.
Conclusion:
Increased stroke severity, proximal vessel occlusion, worse collateral status, and cardioembolism etiology were key features of fast progressors before EVT. Fast progressors exhibit significantly elevated risks of poor outcomes. Taking IGR into consideration during clinical practice and research is essential.
More Related Videos
04:56Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm
Published on: August 1, 2025
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Aneurysm III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...